Cann Group Overview

  • Status
  • Public
  • Stock Symbol
  • CAN
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $0.28
  • (As of Wednesday Closing)

Cann Group General Information

Description

Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the company; the development and manufacture (via third party arrangements) of finished product formulations; and the pursuit and execution of various supply and offtake agreements with third parties.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Cultivation
Pharmaceuticals
Stock Exchange
ASX
Primary Office
  • 4 Research Avenue
  • Bundoora, Victoria 3083
  • Australia
+61 (03) 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cann Group Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.28 $0.28 $0.20 - $0.71 $77.5M 278M 723K

Cann Group Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018
EV 93,608 82,903 158,281 287,088
Revenue 434 1,679 434
EBITDA (9,492) (8,828) (3,643)
Net Income (11,345) (7,812) (3,661)
Total Assets 52,497 57,508 63,763
Total Debt 6,405 0 15
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cann Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cann Group‘s full profile, request access.

Request a free trial

Cann Group Executive Team (2)

Name Title Board Seat Contact Info
Peter Crock Chief Executive Officer
Richard Baker Chief Financial Officer and Company Secretary
To view Cann Group’s complete executive team members history, request access »

Cann Group Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cann Group‘s full profile, request access.

Request a free trial

Cann Group Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 10-Mar-2021 000000000000000000 00.000 Pharmaceuticals 00000 00000
To view Cann Group’s complete acquisitions history, request access »